Health Care & Life Sciences » Pharmaceuticals | Samil Pharmaceutical Co. Ltd.

Samil Pharmaceutical Co. Ltd.

Samil Pharmaceutical Co. Ltd.
Stock Exchange Korea Exchange Commodity Market
EPS
KRW1166.61
Market Cap
KRW164.49 B
Shares Outstanding
6.5 M
Public Float
3.59 M

Profile

Address
155 Hyoryeong-ro
Seoul SL 06666
Korea, Republic Of
Employees -
Website http://www.samil-pharm.com
Updated 07/08/2019
Samil Pharmaceutical Co., Ltd. engages in the development and manufacture of pharmaceutical products. Its products include CNS Drugs, Ophthalmic Drugs, Respiratory Drugs, Genito-urinary Drugs, Antibiotics Chemotherapeutics, Circulatory Drugs, Gastro-Intestinal Drugs, Agents for Diabetes Mellitus, Hormones, Metabolic Drugs, Disinfectants, Amino Acids, Dental Preparations, Antipyretic, Allergy Drugs, Antihistamines, Analgesic and Anti-inflammatory Agents. The company was founded on October 7, 1947 and is headquartered in Seoul, South Korea.

Financials

View All

Kang Huh
Chairman & Co-Chief Executive Officer
Chang-Jin Song
Outside Director